Acromegaly epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
|||
| Line 13: | Line 13: | ||
*The prevalence of acromegaly is approximately 2.8 - 13.7 per 100,000 individuals worldwide.<ref name="pmid33693132">{{cite journal| author=Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B| title=Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. | journal=Acta Med Scand | year= 1988 | volume= 223 | issue= 4 | pages= 327-35 | pmid=3369313 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3369313 }}</ref><ref name="pmid11081170">{{cite journal| author=Holdaway IM, Rajasoorya C| title=Epidemiology of acromegaly. | journal=Pituitary | year= 1999 | volume= 2 | issue= 1 | pages= 29-41 | pmid=11081170 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11081170 }}</ref> | *The prevalence of acromegaly is approximately 2.8 - 13.7 per 100,000 individuals worldwide.<ref name="pmid33693132">{{cite journal| author=Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B| title=Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. | journal=Acta Med Scand | year= 1988 | volume= 223 | issue= 4 | pages= 327-35 | pmid=3369313 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3369313 }}</ref><ref name="pmid11081170">{{cite journal| author=Holdaway IM, Rajasoorya C| title=Epidemiology of acromegaly. | journal=Pituitary | year= 1999 | volume= 2 | issue= 1 | pages= 29-41 | pmid=11081170 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11081170 }}</ref> | ||
===Age=== | ===Age=== | ||
*The incidence of acromegaly increases with age | *The incidence of acromegaly increases with age | ||
*The mean age at diagnosis of acromegaly is 40 years in males. | |||
*The mean age at diagnosis of acromegaly is 45 years in females. | *The mean age at diagnosis of acromegaly is 45 years in females. | ||
Revision as of 21:32, 24 August 2017
|
Acromegaly Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acromegaly epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acromegaly epidemiology and demographics |
|
Risk calculators and risk factors for Acromegaly epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
The prevalence of acromegaly is estimated to be 2.8 - 13.7 per 100.000 individuals worldwide. In the United States, the incidence of acromegaly is 0.11 per 100,000 indvidual. Acromegaly affects men and women equally.
Epidemiology and Demographics
Incidence
Prevalence
Age
- The incidence of acromegaly increases with age
- The mean age at diagnosis of acromegaly is 40 years in males.
- The mean age at diagnosis of acromegaly is 45 years in females.
Race
- There is no racial predilection to acromegaly.
Gender
- Acromegaly affects men and women equally.[6]
Developed Countries
- In the United States, acromegaly is very rare. The incidence of acromegaly in the United States is 0.11 per 100,000 individual.
- In Iceland, the incidence of acromegaly is 0.7 per 100,000 individual.[7]
References
- ↑ Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B (1988). "Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984". Acta Med Scand. 223 (4): 327–35. PMID 3369313.
- ↑ Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017). "Epidemiology of acromegaly: review of population studies". Pituitary. 20 (1): 4–9. doi:10.1007/s11102-016-0754-x. PMC 5334410. PMID 27743174.
- ↑ Dal J, Feldt-Rasmussen U, Andersen M, Kristensen LØ, Laurberg P, Pedersen L; et al. (2016). "Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study". Eur J Endocrinol. 175 (3): 181–90. doi:10.1530/EJE-16-0117. PMID 27280374.
- ↑ Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B (1988). "Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984". Acta Med Scand. 223 (4): 327–35. PMID 3369313.
- ↑ Holdaway IM, Rajasoorya C (1999). "Epidemiology of acromegaly". Pituitary. 2 (1): 29–41. PMID 11081170.
- ↑ Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994). "Acromegaly. Clinical and biochemical features in 500 patients". Medicine (Baltimore). 73 (5): 233–40. PMID 7934807.
- ↑ Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA (2015). "The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013". Pituitary. 18 (6): 803–7. doi:10.1007/s11102-015-0655-4. PMID 25893613.